2013 American Transplant Congress
Practices and Attitudes toward Donor Pain Control in Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
Lahey Clinic; Northwestern U; U of Colorado
IntroductionClinicians at 9 A2ALL centers were surveyed about practices and attitudes toward pain control after donor hepatectomy.MethodsResponses were collected via Survey Monkey. A surgeon (S),…2013 American Transplant Congress
Immunosuppression Regimen and the Risk of Acute Rejection in HIV-Infected Kidney Transplant Recipients
University of Alabama at Birmingham, Birmingham; Johns Hopkins University, Baltimore
Background: Kidney transplantation has been established as the therapy of choice for the treatment of end stage renal disease among appropriately selected HIV-infected (HIV+) individuals.…2013 American Transplant Congress
Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
ObjectiveTo examine tacrolimus (TAC) dose over time and by TAC trough levels in liver transplant (LTX) patients.MethodsA retrospective analysis of transplanted liver and a prescription…2013 American Transplant Congress
Evaluation of Immunocompetence in Tolerant Chimeric Recipients of Hematopoietic Stem Cell/Renal Transplants
We have established high levels of durable chimerism and immunosuppression-free graft survival without GVHD or engraftment syndrome in recipients of living donor facilitating cell/hematopoietic stem…2013 American Transplant Congress
Role of Graft Non-Hematopoietic Cells in Organ Transplant Tolerance, The
Success of organ transplantation currently depends on life-time immunosuppression, resulting in severe side effects. Induction of specific tolerance is ideal, which actually spontaneously occurs following…2013 American Transplant Congress
Potential Importance of 3 Year Surveillance Biopsies in Renal Transplantation
Most renal transplant surveillance biopsies [SBx] are taken within the first 12 months of transplantation and there is growing evidence that the detection of subclinical…2013 American Transplant Congress
Impact of the Determination of HLA Antibodies in Kidney Transplant over Ten Years of Monitoring
Nephrology, Hospital 12 de Octubre, Madrid, Spain
Objetive: The goal of this study was to determine the prevalence of anti-HLA antibodies and the clinical outcome in patients with functioning renal graft over…2013 American Transplant Congress
Everolimus (RAD001) Treatment Effect in Liver Transplantation – A Rational Approach To Quantify the mTOR Effect
The H2304 Study Group, Basel, Switzerland
Background: 12M study results of study CRAD001H2304 (NCT00622869) demonstrated superior renal function and comparable efficacy, including fewer and less severe treated BPAR with everolimus (EVR)…2013 American Transplant Congress
Anti-HLA DP Alpha Alloantibodies Are Associated with High Antibody Levels and Correlate with Individual HLA-DP Beta Epitopes in Renal Transplant Candidates and Recipients
University of Cincinnati, Cincinnati
Anti-HLA DP antibodies have been associated with renal allograft rejection and/or positive crossmatches. While the reactivity of anti-HLA DP Beta antibody (DPΒ-Ab) is described, less…2013 American Transplant Congress
Increased Incidence of Non Anastomotic Biliary Strictures in Case of Donation after Circulatory Death Versus Donation after Brain Death Liver Transplantation but Equivalent Graft and Patient Survival
Because of the concerns regarding short & long-term outcomes after Liver Transplantation (LTx) using Donation after Circulatory Death (DCD) compared to Donation after Brain Death…
- « Previous Page
- 1
- …
- 72
- 73
- 74
- 75
- 76
- …
- 178
- Next Page »